Trial Details

RECRUITING
Basic Information
Clinical ID c782
Identifier NCT06059989
Trial Title InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Disease|Disease Crohn|Bowel Disease
Interventions DRUG: Infliximab subcutaneous|DRUG: Immunosuppressive Agents
Participant Information
Sponsor Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
City North Holland
Country/Region Netherlands
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2021-11-25
Primary Completion Date 2025-06
Completion Date 2025-12